Meyka AI API is live for developers.Start building.
Advertisement
Deep Medicine Acquisition Corp.

Deep Medicine Acquisition Corp. (DMAQ) Stock Overview

Explore Deep Medicine Acquisition Corp.’s financial performance, market position, analyst ratings, and future outlook.

DMAQ●NASDAQ
Financial ServicesShell Companies
$2.96
$5.43(64.72%)
U.S. Market opens in 62h 21m
Advertisement

Deep Medicine Acquisition Corp. (DMAQ)

Meyka AI Score

Z

Key Financials

Market Cap12.9M
P/E Ratio-0.06
EPS (TTM)$-0.13
ROE-3.18%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$11.64

DMAQ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Deep Medicine Acquisition Corp. (DMAQ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $11.64.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.06 and a market capitalization of 12.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-74.37%
6-Month Change
-74.59%
Year-to-Date (YTD) Change
-74.61%
1-Year Change
-71.54%
3-Year Change
-69.95%
5-Year Change
-69.95%
All-Time (Max) Change
-69.95%

Contact Information

NaN
917 289 2776
595 Madison Avenue, New York City, NY, 10017

Company Facts

20 Employees
IPO DateDec 2, 2021
CountryUS

Frequently Asked Questions